What are the bleeding characteristics of endometrial cancer?

Cancer is a disease phenomenon that threatens modern people. There are many types of cancer, such as liver cancer, stomach cancer, etc., and women have more types of cancer than men. Among them, endometrial cancer is a common malignant disease in women, which causes great damage to women's health. Let's take a look at the bleeding characteristics of endometrial cancer.

Endometrial cancer generally presents as vaginal bleeding, especially in postmenopausal women. The possibility of endometrial cancer should be highly suspected. Vaginal discharge increases, and lower abdominal pain occurs when the cancer invades the cervix or surrounding tissues. Late-stage patients develop systemic symptoms such as anemia, weakness, weight loss, cachexia, etc.

Segmental curettage is the most reliable and commonly used method for diagnosing endometrial cancer.

Treatment: Surgery is generally the first choice, especially for early cases. For suspected lymph node metastasis, surgery plus radiotherapy is recommended. Elderly patients with severe complications who cannot tolerate surgery and patients in the late stage who are not suitable for surgery need radiotherapy. Progesterone therapy can be used for patients with advanced or recurrent cancer, those who cannot undergo surgical resection, or those who are young, in the early stage, and who wish to preserve their fertility. Chemotherapy can be considered for those in the late stage who cannot undergo surgery or who relapse after treatment.

For patients with postmenopausal vaginal bleeding, abnormal perimenopausal bleeding or discharge, endometrial cancer and cervical cancer must be ruled out before they can be treated as benign diseases. Patients with the following high-risk factors should be given special attention: those with high-risk factors for endometrial cancer, such as patients with hypertension, diabetes, obesity, polycystic ovary syndrome, infertility, delayed menopause; those with a history of long-term use of estrogen, tamoxifen, or other diseases that increase estrogen; those with a family history of breast cancer or endometrial cancer.